Copyright Reports & Markets. All rights reserved.

Global and United States Non-Invasive Prenatal Screening (NIPS) Market Report & Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Non-Invasive Prenatal Screening (NIPS) Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2017-2022) & (US$ Million) Introduction
    • 1.2 Global Non-Invasive Prenatal Screening (NIPS) Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size for the Year 2017-2028
      • 1.2.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size for the Year 2017-2028
    • 1.3 Non-Invasive Prenatal Screening (NIPS) Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.3.1 The Market Share of United States Non-Invasive Prenatal Screening (NIPS) in Global, 2017 VS 2022 VS 2028
      • 1.3.2 The Growth Rate of Non-Invasive Prenatal Screening (NIPS) Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.4 Non-Invasive Prenatal Screening (NIPS) Market Dynamics
      • 1.4.1 Non-Invasive Prenatal Screening (NIPS) Industry Trends
      • 1.4.2 Non-Invasive Prenatal Screening (NIPS) Market Drivers
      • 1.4.3 Non-Invasive Prenatal Screening (NIPS) Market Challenges
      • 1.4.4 Non-Invasive Prenatal Screening (NIPS) Market Restraints
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Non-Invasive Prenatal Screening (NIPS) by Type

    • 2.1 Non-Invasive Prenatal Screening (NIPS) Market Segment by Type
      • 2.1.1 Trisomy 21
      • 2.1.2 Trisomy 18
      • 2.1.3 Trisomy 13
      • 2.1.4 Sex Chromosome Aneuploidies
      • 2.1.5 Others
    • 2.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017, 2022 & 2028)
    • 2.3 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017-2028)
    • 2.4 United States Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017, 2022 & 2028)
    • 2.5 United States Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017-2028)

    3 Non-Invasive Prenatal Screening (NIPS) by Application

    • 3.1 Non-Invasive Prenatal Screening (NIPS) Market Segment by Application
      • 3.1.1 Clinical Laboratories
      • 3.1.2 Hospital
    • 3.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017, 2022 & 2028)
    • 3.3 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017-2028)
    • 3.4 United States Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017, 2022 & 2028)
    • 3.5 United States Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017-2028)

    4 Global Non-Invasive Prenatal Screening (NIPS) Competitor Landscape by Company

    • 4.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Company
      • 4.1.1 Top Global Non-Invasive Prenatal Screening (NIPS) Companies Ranked by Revenue (2021)
      • 4.1.2 Global Non-Invasive Prenatal Screening (NIPS) Revenue by Player (2017-2022)
    • 4.2 Global Non-Invasive Prenatal Screening (NIPS) Concentration Ratio (CR)
      • 4.2.1 Non-Invasive Prenatal Screening (NIPS) Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Companies of Non-Invasive Prenatal Screening (NIPS) in 2021
      • 4.2.3 Global Non-Invasive Prenatal Screening (NIPS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global Non-Invasive Prenatal Screening (NIPS) Headquarters, Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2017-2022) & (US$ Million) Type
      • 4.3.1 Global Non-Invasive Prenatal Screening (NIPS) Headquarters and Area Served
      • 4.3.2 Global Non-Invasive Prenatal Screening (NIPS) Companies Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2017-2022) & (US$ Million) Type
      • 4.3.3 Date of International Companies Enter into Non-Invasive Prenatal Screening (NIPS) Market
    • 4.4 Companies Mergers & Acquisitions, Expansion Plans
    • 4.5 United States Non-Invasive Prenatal Screening (NIPS) Market Size by Company
      • 4.5.1 Top Non-Invasive Prenatal Screening (NIPS) Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States Non-Invasive Prenatal Screening (NIPS) Revenue by Players (2020, 2021 & 2022)

    5 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region

    • 5.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2017-2028)
      • 5.2.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region: 2017-2022
      • 5.2.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2023-2028)

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth 2017-2028
      • 6.1.2 North America Non-Invasive Prenatal Screening (NIPS) Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 China Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth 2017-2028
      • 6.3.2 Europe Non-Invasive Prenatal Screening (NIPS) Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America Non-Invasive Prenatal Screening (NIPS) Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 Myriad Genetics
      • 7.1.1 Myriad Genetics Company Details
      • 7.1.2 Myriad Genetics Business Overview
      • 7.1.3 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Introduction
      • 7.1.4 Myriad Genetics Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2017-2022)
      • 7.1.5 Myriad Genetics Recent Development
    • 7.2 Illumina
      • 7.2.1 Illumina Company Details
      • 7.2.2 Illumina Business Overview
      • 7.2.3 Illumina Non-Invasive Prenatal Screening (NIPS) Introduction
      • 7.2.4 Illumina Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2017-2022)
      • 7.2.5 Illumina Recent Development
    • 7.3 Progenity
      • 7.3.1 Progenity Company Details
      • 7.3.2 Progenity Business Overview
      • 7.3.3 Progenity Non-Invasive Prenatal Screening (NIPS) Introduction
      • 7.3.4 Progenity Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2017-2022)
      • 7.3.5 Progenity Recent Development
    • 7.4 Natera
      • 7.4.1 Natera Company Details
      • 7.4.2 Natera Business Overview
      • 7.4.3 Natera Non-Invasive Prenatal Screening (NIPS) Introduction
      • 7.4.4 Natera Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2017-2022)
      • 7.4.5 Natera Recent Development
    • 7.5 Yourgene Health
      • 7.5.1 Yourgene Health Company Details
      • 7.5.2 Yourgene Health Business Overview
      • 7.5.3 Yourgene Health Non-Invasive Prenatal Screening (NIPS) Introduction
      • 7.5.4 Yourgene Health Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2017-2022)
      • 7.5.5 Yourgene Health Recent Development
    • 7.6 Roche Sequencing Solutions (RSS)
      • 7.6.1 Roche Sequencing Solutions (RSS) Company Details
      • 7.6.2 Roche Sequencing Solutions (RSS) Business Overview
      • 7.6.3 Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Introduction
      • 7.6.4 Roche Sequencing Solutions (RSS) Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2017-2022)
      • 7.6.5 Roche Sequencing Solutions (RSS) Recent Development
    • 7.7 Eurofins LifeCodexx GmbH
      • 7.7.1 Eurofins LifeCodexx GmbH Company Details
      • 7.7.2 Eurofins LifeCodexx GmbH Business Overview
      • 7.7.3 Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Introduction
      • 7.7.4 Eurofins LifeCodexx GmbH Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2017-2022)
      • 7.7.5 Eurofins LifeCodexx GmbH Recent Development
    • 7.8 Labcorp
      • 7.8.1 Labcorp Company Details
      • 7.8.2 Labcorp Business Overview
      • 7.8.3 Labcorp Non-Invasive Prenatal Screening (NIPS) Introduction
      • 7.8.4 Labcorp Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2017-2022)
      • 7.8.5 Labcorp Recent Development
    • 7.9 PerkinElmer
      • 7.9.1 PerkinElmer Company Details
      • 7.9.2 PerkinElmer Business Overview
      • 7.9.3 PerkinElmer Non-Invasive Prenatal Screening (NIPS) Introduction
      • 7.9.4 PerkinElmer Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2017-2022)
      • 7.9.5 PerkinElmer Recent Development
    • 7.10 Harmony
      • 7.10.1 Harmony Company Details
      • 7.10.2 Harmony Business Overview
      • 7.10.3 Harmony Non-Invasive Prenatal Screening (NIPS) Introduction
      • 7.10.4 Harmony Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2017-2022)
      • 7.10.5 Harmony Recent Development

    8 Research Findings and Conclusion

      9 Appendix

      • 9.1 Research Methodology
        • 9.1.1 Methodology/Research Approach
        • 9.1.2 Data Source
      • 9.2 Author Details

      Summary:

      Market Analysis and Insights: Global and United States Non-Invasive Prenatal Screening (NIPS) Market
      This report focuses on global and United States Non-Invasive Prenatal Screening (NIPS) market, also covers the segmentation data of other regions in regional level and county level.
      Due to the COVID-19 pandemic, the global Non-Invasive Prenatal Screening (NIPS) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Trisomy 21 accounting for % of the Non-Invasive Prenatal Screening (NIPS) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Clinical Laboratories was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
      In United States the Non-Invasive Prenatal Screening (NIPS) market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
      Global Non-Invasive Prenatal Screening (NIPS) Scope and Market Size
      Non-Invasive Prenatal Screening (NIPS) market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Non-Invasive Prenatal Screening (NIPS) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
      For United States market, this report focuses on the Non-Invasive Prenatal Screening (NIPS) market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
      Segment by Type, the Non-Invasive Prenatal Screening (NIPS) market is segmented into
      Trisomy 21
      Trisomy 18
      Trisomy 13
      Sex Chromosome Aneuploidies
      Others
      Segment by Application, the Non-Invasive Prenatal Screening (NIPS) market is segmented into
      Clinical Laboratories
      Hospital
      Regional and Country-level Analysis
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      China Taiwan
      Indonesia
      Thailand
      Malaysia
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Competitive Landscape and Non-Invasive Prenatal Screening (NIPS) Market Share Analysis
      Non-Invasive Prenatal Screening (NIPS) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Non-Invasive Prenatal Screening (NIPS) business, the date to enter into the Non-Invasive Prenatal Screening (NIPS) market, Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2017-2022) & (US$ Million) introduction, recent developments, etc.
      The major vendors covered:
      Myriad Genetics
      Illumina
      Progenity
      Natera
      Yourgene Health
      Roche Sequencing Solutions (RSS)
      Eurofins LifeCodexx GmbH
      Labcorp
      PerkinElmer
      Harmony
      Buy now